BIOSKRYB GENOMICS
LIVE

Serial Number

90466612

Owner

BioSkryb, Inc.

Attorney

Samantha C. Markley

First Use Date

Apr 29, 2021

Filing Date

Jan 14, 2021

Add to watchlist:

No watchlists yet
View on USPTO

BIOSKRYB GENOMICS Trademark

Serial Number: 90466612 • Registration: 8161427

BIOSKRYB GENOMICS is a trademark filed by BioSkryb, Inc. on January 14, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

BioSkryb, Inc. (7 trademarks)

701 West Main Street, Suite 200
Durham, NC 27701

Entity Type: 03

BIOSKRYB GENOMICS, INC. (7 trademarks)

Durham, NC 27713

Entity Type: 03

Trademark Details

Filing Date

January 14, 2021

Registration Date

March 3, 2026

First Use Anywhere

April 29, 2021

First Use in Commerce

May 24, 2021

Published for Opposition

November 22, 2022

Goods & Services

Medical testing for diagnostic or treatment purposes; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical diagnostic testing, monitoring and reporting services

Gene and genetic testing apparatus in the nature of apparatus for DNA and RNA testing for medical and scientific purposes; medical apparatus and instruments, namely, a thermal mixer and plate spinner for the amplification and recovery of genomic material for medical purposes; medical apparatus and instruments, namely, magnetic plates for use with magnetic and paramagnetic beads for the processing, purification, and cleanup of samples containing genomic material, including material from single cells

Genomic analysis and sequencing services for scientific, medical, and research purposes; medical and scientific research in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; nucleic acid and ribonucleic acid analysis services for medical and scientific research purposes; providing medical and scientific research information in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta genomics, meta-transcriptomics, and microbiomics; medical and scientific research in connection with high-quality single-cell and low input DNA amplification, primary template-directed amplification (PTA) reaction and library cleanup, optimum bead cleanup performance, single-cell and low-input transcriptional profiling, and combined genome and transcriptome profiling; medical and scientific research in connection with genome amplification to detect genetic variants in cells; medical and scientific research in connection with measuring genetic diversity in single cells; medical and scientific research in connection with primary template-directed amplification for use in connection with single cells and ultra-low DNA input samples; medical and scientific research for the purpose of elevating single cell genome variants for the purpose of genome amplification; DNA analysis and sequencing services for scientific, medical, and research purposes; research, development and scientific consultancy in the field of genomics; medical research, namely, compiling data for research purposes in the field of genomics; providing medical research information in the field of genomics, gene therapy, cell therapy for medical purposes; providing on-line non-downloadable software for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta transcriptomics, and microbiomics; platform as a service (PAAS) featuring computer software platforms for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; software as a service (SAAS) services featuring software for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; providing temporary use of non-downloadable computer software for bioinformatic DNA sequencing analysis for the purpose of allowing users to evaluate data quality, compare results between cells and samples, and integrate multi-omics data; providing temporary use of non-downloadable computer software for bioinformatic DNA sequencing analysis for evaluating data, namely, sequencing alignment, coverage, and single nucleotide, structural, and copy number variant calling metrics; providing temporary use of non-downloadable computer software for genomic analysis and sequencing for scientific, medical, and research purposes; providing temporary use of non-downloadable computer software for medical and scientific research in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta genomics, meta-transcriptomics, and microbiomics; providing temporary use of non-downloadable computer software for nucleic acid and ribonucleic acid analysis for medical and scientific research purposes; providing temporary use of non-downloadable computer software for providing medical and scientific research information in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; providing temporary use of non-downloadable computer software for medical and scientific research in connection with high-quality single-cell and low-input DNA amplification, primary template-directed amplification (PTA) reaction and library cleanup, optimum bead cleanup performance, single-cell and low-input transcriptional profiling, and combined genome and transcriptome profiling; providing temporary use of non-downloadable computer software for medical and scientific research in connection with genome amplification to detect genetic variants in cells; providing temporary use of non-downloadable computer software for medical and scientific research in connection with measuring genetic diversity in single cells; providing temporary use of non-downloadable computer software for medical and scientific research in connection with primary template-directed amplification for use in connection with single cells and ultra-low DNA input samples; providing temporary use of non-downloadable computer software for medical and scientific research for the purpose of elevating single cell genome variants for the purpose of genome amplification; providing temporary use of non-downloadable computer software for DNA analysis and sequencing for scientific, medical, and research purposes; providing temporary use of non-downloadable computer software for compiling data for research purposes in the field of genomics; providing temporary use of non-downloadable computer software for providing medical research information in the field of genomics, gene therapy, cell therapy for medical purposes; providing temporary use of non-downloadable computer software for medical testing, diagnosis, and treatment; providing temporary use of non-downloadable computer software for bioinformatic DNA sequencing analysis for biomarker discovery and annotation for use in connection with offering medical analysis services for diagnostic and treatment purposes provided by medical laboratories; providing temporary use of non-downloadable computer software for use in connection with medical diagnostic testing, monitoring, and reporting; providing temporary use of non-downloadable computer software for medical analysis and diagnosis in connection with the fields of oncology, cardiology, prenatal genetic testing (PGT), neurological genetic disorders, immunology, microbiome, toxicology, and bioprocessing; providing temporary use of non-downloadable computer software for medical analysis and diagnosis in the field of gene therapy and cell therapy

Assays and reagents for use in genetic research; diagnostic reagents for scientific and research use; diagnostic reagents for clinical or medical laboratory use; reagents for scientific use; reagents for scientific use for use in kits for high-quality single-cell and low-input DNA amplification, primary template-directed amplification (PTA) reaction and library cleanup, optimum bead cleanup performance, single-cell and low-input transcriptional profiling, and combined genome and transcriptome profiling; reagents and containers specifically adapted for reagents, namely, reagents comprising paramagnetic beads for use in the processing, purification, and cleanup of samples containing genomic material, including material from single cells, for research purposes; reagents and containers specifically adapted for reagents, namely, reagents for scientific use for use in the amplification and recovery of genomic material, including genomic material from single cells; chemical substances and products, namely, chemical preparations for use in genomic research; biochemicals, namely, biological reagents for use in whole genome amplification to detect genetic variants in each cell for non-medical purposes; laboratory chemicals, namely, an antibody reagent used for genomic research; chemical test kits for diagnostic purposes for laboratory and research use; diagnostic kits comprising reagents for scientific use; diagnostic kits comprised of reagents and assays for scientific use for detecting, testing, analyzing, and sequencing genes, nucleic acids, and biological molecules; medical test kits comprised of reagents for scientific use for biological analysis for use in whole genome amplification to detect genetic variants in cells; kits comprising reagents, namely, reagents for scientific use comprising paramagnetic beads for use in the processing, purification, and cleanup of samples containing genomic material, including material from single cells; kits containing assays, reagents, and chemical preparation for use in genomic research; kits containing biochemicals, namely, biological reagents for scientific use for use in whole genome amplification to detect genetic variants in each cell; kits comprised of cells and biological tissue sample specimens for diagnostic purposes for laboratory or research use; laboratory apparatus and instruments, namely, chemical genomic testing kits; kits containing laboratory chemicals, namely, antibody reagents used for genomic research

Downloadable computer software for bioinformatic DNA sequencing analysis for the purpose of allowing users to evaluate data quality, compare results between cells and samples, and integrate multi omics data; downloadable computer software for bioinformatic DNA sequencing analysis for evaluating data, namely, sequencing alignment, coverage, and single nucleotide, structural, and copy number variant calling metrics; downloadable computer software for genomic analysis and sequencing for scientific, medical, and research purposes; downloadable computer software for medical and scientific research in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta transcriptomics, and microbiomics; downloadable computer software for nucleic acid and ribonucleic acid analysis for medical and scientific research purposes; downloadable computer software for providing medical and scientific research information in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; downloadable computer software for medical and scientific research in connection with high-quality single-cell and low input DNA amplification, primary template-directed amplification (PTA) reaction and library cleanup, optimum bead cleanup performance, single-cell and low-input transcriptional profiling, and combined genome and transcriptome profiling; downloadable computer software for medical and scientific research in connection with genome amplification to detect genetic variants in cells; downloadable computer software for medical and scientific research in connection with measuring genetic diversity in single cells; downloadable computer software for medical and scientific research in connection with primary template-directed amplification for use in connection with single cells and ultra-low DNA input samples; downloadable computer software for DNA analysis and sequencing for scientific, medical, and research purposes; downloadable computer software for research, development and consultancy in the field of genomics; downloadable computer software for compiling data for research purposes in the field of genomics; downloadable computer software for providing medical research information in the field of genomics, gene therapy, cell therapy for medical purposes; downloadable computer software for medical testing, diagnosis, and treatment; downloadable computer software for bioinformatic DNA sequencing analysis for biomarker discovery and annotation for use in connection with offering medical analysis services for diagnostic and treatment purposes provided by medical laboratories; downloadable computer software for medical diagnostic testing, monitoring, and reporting; downloadable computer software for medical analysis and diagnosis in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta genomics, meta-transcriptomics, and microbiomics

Diagnostic reagents for medical use; reagents and containers specifically adapted for reagents, namely, reagents comprising paramagnetic beads for use in the processing, purification, and cleanup of samples containing genomic material, including material from single cells, for medical purposes; medical test kits comprised of medical diagnostic reagents and assays for high-quality single-cell and low-input DNA amplification, primary template-directed amplification (PTA) reaction and library cleanup, optimum bead cleanup performance, single-cell and low-input transcriptional profiling, and combined genome and transcriptome profiling; medical test kits comprised of medical diagnostic reagents for use in the amplification and recovery of genomic material, including genomic material from single cells; kits comprising reagents, namely, reagents for medical use comprising paramagnetic beads for use in the processing, purification, and cleanup of samples containing genomic material, including material from single cells; diagnostic kits comprising reagents for medical use

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 24, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 24, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 24, 2026 REAP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 11, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 11, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 11, 2026 REAP
WITHDRAWAL OF ATTORNEY GRANTED
Mar 4, 2026 WOAG
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Mar 4, 2026 WOAR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 3, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Mar 3, 2026 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Feb 11, 2026 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Feb 11, 2026 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Jan 20, 2026 SUPC
USE AMENDMENT FILED
Jan 15, 2026 IUAF
TEAS STATEMENT OF USE RECEIVED
Jan 15, 2026 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 19, 2025 EXRA
SOU EXTENSION 5 GRANTED
Dec 18, 2025 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 15, 2025 AITU
SOU TEAS EXTENSION RECEIVED
Jul 14, 2025 EEXT
SOU EXTENSION 5 FILED
Jul 13, 2025 EXT5
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 3, 2025 EXRA
SOU EXTENSION 4 GRANTED
Jan 4, 2025 EX4G
SOU EXTENSION 4 FILED
Jan 3, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
Jan 3, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 9, 2024 EXRA
SOU EXTENSION 3 GRANTED
Jul 9, 2024 EX3G
SOU EXTENSION 3 FILED
Jul 9, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Jul 9, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 10, 2024 EXRA
SOU EXTENSION 2 GRANTED
Jan 8, 2024 EX2G
SOU EXTENSION 2 FILED
Jan 8, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Jan 8, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 7, 2023 EXRA
SOU EXTENSION 1 GRANTED
Jul 5, 2023 EX1G
SOU EXTENSION 1 FILED
Jul 5, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Jul 5, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 17, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 22, 2022 NPUB
PUBLISHED FOR OPPOSITION
Nov 22, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 2, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 17, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 17, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 17, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 17, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 17, 2022 CNEA
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Sep 2, 2022 GEAN
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Sep 2, 2022 GEAP
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Sep 2, 2022 EPEN
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Sep 2, 2022 CPEA
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Aug 19, 2022 GNS1
CONTINUATION OF FINAL REFUSAL E-MAILED
Aug 19, 2022 GNCF
ACTION CONTINUING A FINAL - COMPLETED
Aug 19, 2022 CNCF
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 28, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 27, 2022 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jul 27, 2022 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Feb 2, 2022 GNFN
FINAL REFUSAL E-MAILED
Feb 2, 2022 GNFR
FINAL REFUSAL WRITTEN
Feb 2, 2022 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 1, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 1, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 1, 2022 TROA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 17, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 17, 2021 TCCA
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 17, 2021 COAR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 2, 2021 GNRN
NON-FINAL ACTION E-MAILED
Aug 2, 2021 GNRT
NON-FINAL ACTION WRITTEN
Aug 2, 2021 CNRT
ASSIGNED TO EXAMINER
Jul 26, 2021 DOCK
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jun 2, 2021 ASGN
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 15, 2021 NWOS
NEW APPLICATION ENTERED
Jan 18, 2021 NWAP